Skip to main content

NVR DU (Tabrecta 150 mg)

Generic Name: capmatinib

Pill with imprint NVR DU is Brown, Elliptical / Oval and has been identified as Tabrecta 150 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Tabrecta is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. Tabrecta 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR DU

Tabrecta

Generic Name
capmatinib
Imprint
NVR DU
Strength
150 mg
Color
Brown
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals Corporation
National Drug Code (NDC)
00078-0709

Get help with Imprint Code FAQs.

Related Images for "NVR DU"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.